APOBEC-Induced Mutations at Initiation of Cabotegravir + Rilpivirine for Two Patients Infected by HIV-1 Subtype CRF02: The Interest of Systematic Genotyping

J Acquir Immune Defic Syndr. 2023 Mar 1;92(3):e17-e18. doi: 10.1097/QAI.0000000000003148.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-HIV Agents* / pharmacology
  • Anti-HIV Agents* / therapeutic use
  • Anti-Retroviral Agents / therapeutic use
  • Genotype
  • HIV Infections* / drug therapy
  • HIV-1* / genetics
  • Humans
  • Mutation
  • Pyridones / therapeutic use
  • Rilpivirine / therapeutic use

Substances

  • cabotegravir
  • Anti-Retroviral Agents
  • Rilpivirine
  • Pyridones
  • Anti-HIV Agents